↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$5.1MSold on the market
1Companies
Oct 2, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202621:30 | Oct 1, 2026 | SYRESpyre Therapeutics, Inc. | See Remarks | S · Sell10b5-1 | $91.03 | −28,933 | 2,845 | -91% | −$2.6M | ||
| Oct 2, 202621:30 | Oct 1, 2026 | SYRESpyre Therapeutics, Inc. | See Remarks | M · Exercise10b5-1 | $14.50 | +28,933 | 31,778 | +1017% | $420K | ||
| Sep 3, 202621:34 | Sep 2, 2026from Sep 1, 2026 | SYRESpyre Therapeutics, Inc. | See Remarks | S · Sell10b5-1 | $87.35 | −28,399 | 2,845 | -91% | −$2.5M | ||
| Sep 3, 202621:34 | Sep 2, 2026from Sep 1, 2026 | SYRESpyre Therapeutics, Inc. | See Remarks | M · Exercise10b5-1 | $14.50 | +28,399 | 3,245 | — | $412K |